Literature DB >> 16677891

Increased CXCR3 expression associated with CD3-positive lymphocytes in the liver and biliary remnant in biliary atresia.

Masato Shinkai1, Toko Shinkai, Prem Puri, Mark D Stringer.   

Abstract

BACKGROUND: Lymphocyte-mediated inflammatory damage of the bile ducts has been proposed as a potential mechanism in the pathogenesis of biliary atresia (BA). Chemokines regulate leukocyte migration and act as critical organizers of cell distribution in inflammatory responses. The aim of this study was to analyze the infiltration of T lymphocytes and the expression of a chemokine receptor, CXCR3, predominantly expressed on type 1 polarized T cells (T(H)1, T(C)1) in the liver and excised biliary remnants in infants with BA.
METHODS: Immunohistochemistry for CD3, CD8, and CXCR3 was performed using liver biopsy specimens collected from the following 3 age-matched groups of patients: group 1, BA (nonsyndromic) at the time of Kasai portoenterostomy (n = 10); group 2, congenital choledochal dilatation (n = 2); and group 3, other cholestatic diseases including paucity of intrahepatic bile ducts and cholestasis (n = 3) related to total parenteral nutrition. Cellular staining on each section was graded from 0 to 4 and compared using nonparametric statistics.
RESULTS: Infiltrating CD3+ and CD8+ lymphocytes in the portal tracts were significantly increased in group 1 (3.1 +/- 0.4, 2.8 +/- 0.4), compared with groups 2 (1.0 +/- 0.0, 1.0 +/- 0.0) and 3 (1.7 +/- 0.3, 1.5 +/- 0.5) (P < .01, P < .05). CXCR3+ mononuclear cells were significantly increased in group 1 (2.6 +/- 0.3) compared with groups 2 (0.5 +/- 0.5) and 3 (0.7 +/- 0.3) (P < .05). They were mainly found in the portal tracts with a similar distribution to CD3+ cells. CXCR3+ cells and CD3+ cells also showed a similar distribution in specimens of biliary remnants from just below the portal plate.
CONCLUSIONS: Increased expression of CXCR3 associated with a significantly increased CD3 and CD8 T-cell infiltration suggests that CXCR3+ lymphocytes in a type 1 (T(H)1, T(C)1) cytokine milieu may play a role in the pathogenesis of BA.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16677891     DOI: 10.1016/j.jpedsurg.2006.01.060

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  14 in total

1.  No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model.

Authors:  Gustavo Villalona; Amber Price; Keith Blomenkamp; Chandrashekhara Manithody; Saurabh Saxena; Thomas Ratchford; Matthew Westrich; Vindhya Kakarla; Shruthika Pochampally; William Phillips; Nicole Heafner; Niraja Korremla; Jose Greenspon; Miguel A Guzman; Ajay Kumar Jain
Journal:  JPEN J Parenter Enteral Nutr       Date:  2018-04-27       Impact factor: 4.016

Review 2.  Biliary atresia: cellular dynamics and immune dysregulation.

Authors:  Amy G Feldman; Cara L Mack
Journal:  Semin Pediatr Surg       Date:  2012-08       Impact factor: 2.754

Review 3.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

4.  Paediatric cholestatic liver disease: Diagnosis, assessment of disease progression and mechanisms of fibrogenesis.

Authors:  Tamara N Pereira; Meagan J Walsh; Peter J Lewindon; Grant A Ramm
Journal:  World J Gastrointest Pathophysiol       Date:  2010-06-15

5.  Neonatal NK cells target the mouse duct epithelium via Nkg2d and drive tissue-specific injury in experimental biliary atresia.

Authors:  Pranavkumar Shivakumar; Gregg E Sabla; Peter Whitington; Claire A Chougnet; Jorge A Bezerra
Journal:  J Clin Invest       Date:  2009-08       Impact factor: 14.808

Review 6.  Update on investigations pertaining to the pathogenesis of biliary atresia.

Authors:  Alexandra Kilgore; Cara L Mack
Journal:  Pediatr Surg Int       Date:  2017-10-24       Impact factor: 1.827

7.  MicroRNA-155 modulates bile duct inflammation by targeting the suppressor of cytokine signaling 1 in biliary atresia.

Authors:  Rui Zhao; Rui Dong; Yifan Yang; Yuqing Wang; Jin Ma; Jiang Wang; Hao Li; Shan Zheng
Journal:  Pediatr Res       Date:  2017-09-06       Impact factor: 3.756

Review 8.  Biliary atresia: recent progress.

Authors:  Mikelle D Bassett; Karen F Murray
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

9.  Both Th1 and Th17 are immunopathogenic but differ in other key biological activities.

Authors:  Catherine A Cox; Guangpu Shi; Hongen Yin; Barbara P Vistica; Eric F Wawrousek; Chi-Chao Chan; Igal Gery
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

10.  Cholangiocyte secretion of chemokines in experimental biliary atresia.

Authors:  Mubeen Jafri; Bryan Donnelly; Alex Bondoc; Steven Allen; Greg Tiao
Journal:  J Pediatr Surg       Date:  2009-03       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.